{"nct_id":"NCT02461589","title":"Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes","status":"COMPLETED","status_verified_date":"2019-07","start_date":"2015-09-21","start_date_type":"ACTUAL","primary_completion_date":"2016-10-13","primary_completion_date_type":"ACTUAL","completion_date":"2016-10-13","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVO"]}